Tag: Respiratory Problems: Misc.
Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis
Annualized rate of pulmonary exacerbations lower in 10-mg and 25-mg brensocatib groups versus placebo
Medically Tailored Meals Are Saving Costs in 49 States
Meals are cost-saving assuming full uptake among eligible patients with diet-related diseases, limitations in activities of daily living
Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility
78.5 percent of unvaccinated adults are unsure if they were eligible for vaccination or thought they were not
One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures
Authors call for continued research and surveillance to further characterize occupational risk factors
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
No significant difference seen in odds of postoperative pneumonia between adult GLP-1 receptor agonist users and nonusers
PREFUL MRI Reveals Distinct Lung Phenotype in Children With Long COVID
Children and adolescents with post-COVID-19 condition have lower regional ventilation and quantified perfusion
Most Children With Multisystem Inflammatory Syndrome Recover by Six Months
Cardiovascular and noncardiovascular morbidities rare by six months, despite severe illness in acute phase
Reporting of Human Adenoviruses Has Declined Since COVID-19
Six HAdV types accounted for 88.3 percent of typed specimens reported during 2017 to 2023
Children With Primary Ciliary Dyskinesia Likely to Have Asthma
Adjusted odds ratio for asthma was 22.3 for patients with bronchiectasis and situs inversus totalis, indicative of PCD
RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults
Vaccine effectiveness 91 percent using strict controls in a population of adults aged 60 years or older
